Health Care & Life Sciences » Pharmaceuticals | Knight Therapeutics Inc.

Knight Therapeutics Inc. | Income Statement

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
365.30
1,037.00
5,940.00
8,634.00
12,500
Cost of Goods Sold (COGS) incl. D&A
-
-
552.00
1,987.00
3,214.00
4,237
Gross Income
-
-
485.00
3,953.00
5,420.00
8,263
SG&A Expense
-
5,312.00
11,793.00
11,789.00
14,326.00
14,046
EBIT
-
5,031.80
11,308.00
7,836.00
8,906.00
5,783
Unusual Expense
-
15.70
650.00
910.00
692.00
1,188
Non Operating Income/Expense
-
132,193.40
29,301.00
5,012.00
2,259.00
12,570
Interest Expense
-
23.50
-
-
-
-
Pretax Income
-
131,053.60
35,975.00
20,680.00
20,345.00
28,909
Income Tax
-
5,194.80
2,849.00
4,913.00
3,955.00
5,385
Equity in Affiliates
-
-
1,041.00
2,793.00
854.00
555
Consolidated Net Income
-
125,858.90
34,167.00
18,560.00
17,244.00
24,079
Net Income
-
125,858.90
34,167.00
18,560.00
17,244.00
24,079
Net Income After Extraordinaries
0.00
125,858.90
34,167.00
18,560.00
17,244.00
24,079
Net Income Available to Common
-
125,858.90
34,167.00
18,560.00
17,244.00
24,079
EPS (Basic)
-
2.20
0.36
0.15
0.12
0.17
Basic Shares Outstanding
22,036.10
57,248.50
96,191.30
120,723.30
142,763.70
142,827.60
EPS (Diluted)
-
2.20
0.35
0.15
0.12
0.17
Diluted Shares Outstanding
22,036.10
57,295.70
96,532.10
121,263.50
143,416.70
143,275
EBITDA
-
4,946.60
11,184.00
7,399.00
7,277.00
3,851
Non-Operating Interest Income
-
3,899.90
18,632.00
24,414.00
26,300.00
20,934

About Knight Therapeutics

View Profile
Address
3400, de Maisonneuve Boulevard West
Montréal Québec H3Z 3B8
Canada
Employees -
Website http://www.gud-knight.com
Updated 07/08/2019
Knight Therapeutics Inc engages in developing, acquiring, in-licensing, out-licensing, marketing, and distributing pharmaceutical products, consumer health products, and medical devices. It offers commercialized Rx and over-the-counter products, which includes Impavido, Movantik, ATryn, and AzaSite. The company was founded by Jonathan Ross Goodman on November 1, 2013 and is headquartered in Montreal, Canada.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.